·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of May 29, 2023

In the news: Eligible Americans lose Medicaid coverage, impact of exercise on brain health, FDA issues warning on off-brand semaglutide and more.

Publications & Newsletters
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of May 22, 2023

In the news: Benefits of semaglutide, surgeon general warns of social media risks, implants help paralyzed man walk, key long COVID symptoms identified and more.

Publications & Newsletters
·
10 Min Read

May 19, 2023: National Advocacy Update

 Senate Committee passes bipartisan PBM legislation and more in the latest National Advocacy Update.

Advocacy Update
·
1 Min Read

AMA statement on DEA extending telehealth prescription flexibilities

The AMA applauds the DEA extending flexibilities in the prescribing of controlled substances through telehealth visits through Nov. 11, 2023.

Press Releases
Mifepristone
·
5 Min Read

Next steps in mifepristone court fight: What doctors should know

Federal appeals court will hear arguments on order that would prevent access to a safe and effective reproductive health care option. Learn more.

Judicial Advocacy
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 20, 2023

In the news: Alarming spread of deadly and drug-resistant Candida auris fungus, growing drug shortages, autism spectrum disorder on the rise and more.

Publications & Newsletters
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Feb. 13, 2023

In the news: children missing out on vital nutrition, early indicators of CVD and cognitive ability, COVID-19’s link to diabetes, FDA drug approvals and more.

Publications & Newsletters
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of Jan. 9, 2023

In the news: Cancer mortality down 33%, duration of long COVID symptoms, dementia's link to hearing loss, FDA approval for Alzheimer’s drug and more.

Publications & Newsletters
People in conference room, seen through semi-opaque glass wall
·
4 Min Read

How the 10 largest PBMs hold huge sway in health care marketplace

First-of-its-kind data on pharmacy benefit managers (PBMs) analyzed in AMA report shows widespread, high market concentration.

Access to Care